Arcutis Biotherapeutics Inc (ARQT)

12:49 PM

Is Arcutis Biotherapeutics Inc. stock undervalued vs historical averagesWeekly Volume Report & Target Return Focused Picks - newser.com

12:49 PM

12:48 PM

Leading vs lagging indicators on Arcutis Biotherapeutics Inc. performancePortfolio Profit Report & Reliable Price Breakout Alerts - newser.com

12:48 PM

12:41 PM

Will Arcutis Biotherapeutics Inc. stock deliver consistent dividendsJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com

12:41 PM

09:34 AM

How Arcutis Biotherapeutics Inc. stock reacts to global recession fearsTrend Reversal & Weekly Setup with High ROI Potential - newser.com

09:34 AM

08:55 AM

HC Wainwright Has Positive Forecast for ARQT FY2025 Earnings - MarketBeat

08:55 AM

07:43 AM

Arcutis Biotherapeutics (NASDAQ:ARQT) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat

07:43 AM

05:48 AM

Multi asset correlation models including Arcutis Biotherapeutics Inc.Quarterly Investment Review & Daily Oversold Bounce Ideas - newser.com

05:48 AM

03:31 AM

Advanced analytics toolkit walkthrough for Arcutis Biotherapeutics Inc.2025 Risk Factors & Reliable Breakout Forecasts - newser.com

03:31 AM

01:21 AM

How Arcutis Biotherapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Institutional & Verified Swing Trading Watchlist - newser.com

01:21 AM

01:17 AM

What’s the recovery path for long term holders of Arcutis Biotherapeutics Inc.July 2025 PreEarnings & Growth Focused Entry Point Reports - newser.com

01:17 AM

Oct 31, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 40,000 Shares - MarketBeat

Oct 31, 2025

Oct 31, 2025

Why Arcutis Biotherapeutics (ARQT) Is Up 23.9% After Expanding ZORYVE to Pediatric Atopic Dermatitis - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

HC Wainwright Has Positive Outlook for ARQT Q4 Earnings - MarketBeat

Oct 31, 2025

Oct 31, 2025

Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Results: Arcutis Biotherapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st

Oct 31, 2025

Oct 31, 2025

What the charts say about Arcutis Biotherapeutics Inc. todayChart Signals & Reliable Price Action Trade Plans - newser.com

Oct 31, 2025

Oct 31, 2025

How high can Arcutis Biotherapeutics Inc. stock go2025 Institutional Moves & Breakout Confirmation Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Is Arcutis Biotherapeutics Inc. stock dividend yield sustainableQuarterly Trade Summary & Fast Moving Stock Watchlists - newser.com

Oct 31, 2025

Oct 31, 2025

Is Arcutis Biotherapeutics Inc. stock poised for growthJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Is Arcutis Biotherapeutics Inc. stock safe for conservative investors2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Is Arcutis Biotherapeutics Inc. a candidate for recovery playJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - newser.com

Oct 31, 2025

Oct 31, 2025

Volatility clustering patterns for Arcutis Biotherapeutics Inc.Trade Exit Report & Advanced Swing Trade Entry Plans - newser.com

Oct 31, 2025

Oct 30, 2025

Arcutis Biotherapeutics CEO Watanabe sells $1m in shares By Investing.com - Investing.com Nigeria

Oct 30, 2025

Oct 30, 2025

Arcutis Biotherapeutics CEO Watanabe sells $1m in shares - Investing.com

Oct 30, 2025

Oct 30, 2025

Goldman Sachs Maintains Arcutis Biotherapeutics (ARQT) Neutral Recommendation - Nasdaq

Oct 30, 2025

Oct 30, 2025

Roflumilast Cream 0.05% Now Commercially Available for Pediatric Atopic Dermatitis - Dermatology Times

Oct 30, 2025

Oct 30, 2025

What Makes Arcutis Biotherapeutics (ARQT) a New Strong Buy Stock - Yahoo Finance

Oct 30, 2025

Oct 30, 2025

Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics in the Free to Be Me Campaign, Urging People With Inflammatory Skin Conditions to Speak With Their Healthcare Provider About Long-Term Treatments - The Manila Times

Oct 30, 2025

Oct 30, 2025

Tori Spelling Joins Arcutis Biotherapeutics in Launching Free to Be Me Campaign to Raise Awareness About Eczema and Seborrheic Dermatitis - Quiver Quantitative

Oct 30, 2025

Oct 30, 2025

Arcutis (NASDAQ: ARQT) joins Tori Spelling in 'Free to Be Me' for 36M patients - Stock Titan

Oct 30, 2025

Oct 30, 2025

Arcutis Biotherapeutics (ARQT) Launches ZORYVE Cream for Young C - GuruFocus

Oct 30, 2025

Oct 30, 2025

Arcutis Biotherapeutics launches new topical cream for children's eczema - Traders Union

Oct 30, 2025

Oct 30, 2025

Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5 - MarketScreener

Oct 30, 2025

Oct 30, 2025

Arcutis (NASDAQ: ARQT) launches ZORYVE 0.05% cream for children 2–5 with atopic dermatitis - Stock Titan

Oct 30, 2025

Oct 30, 2025

Will earnings trigger a reversal in Arcutis Biotherapeutics Inc.Market Weekly Review & AI Driven Price Predictions - newser.com

Oct 30, 2025

Oct 30, 2025

Arcutis Biotherapeutics, Inc. $ARQT Stake Lowered by Jennison Associates LLC - MarketBeat

Oct 30, 2025

Oct 30, 2025

Why hedge funds are buying Arcutis Biotherapeutics Inc. stockJuly 2025 Market Mood & High Return Trade Guides - newser.com

Oct 30, 2025

Oct 30, 2025

Will a bounce in Arcutis Biotherapeutics Inc. offer an exitJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - newser.com

Oct 30, 2025

Oct 30, 2025

Has Arcutis Biotherapeutics Inc. found a price floorMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com

Oct 30, 2025

Oct 30, 2025

How Arcutis Biotherapeutics Inc. stock reacts to inflationary pressures2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 01:04:15 - newser.com

Oct 30, 2025

Oct 29, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Given New $30.00 Price Target at Needham & Company LLC - MarketBeat

Oct 29, 2025

Oct 29, 2025

Arcutis Swings Into Profit As Skin Therapy Soars - Citeline News & Insights

Oct 29, 2025